本刊特点：目次收录（知网）,2022-2023不收版面费,外文期刊,
期刊基本信息
出版周期：季刊 级别：国际刊号
中国国内刊号：无CN号
国际标准刊号：ISSN 2769-6448
杂志社联系方式
地址：四川省成都市高新区环球中心S2区6栋1103-1105号
邮编：610041
电话：028-80592559-8002
微信公众号：四川省国际医学交流促进会（scimea）
官网邮箱：editorial@med-comm.org
官方网站：https://onlinelibrary.wiley.com/journal/27696448
杂志征稿投稿要求
MedComm – Oncology创刊，欢迎投稿
【微信公众号“四川省国际医学交流促进会（scimea）”信息】
SCIMEA 四川省国际医学交流促进会 2022-02-24
国产潜力股，肿瘤学新刊MedComm – Oncology目前开放投稿，预计4月正式上线出版。期刊采用连续出版模式，文章及时上线和更快索引，欢迎投稿。
MedComm – Oncology由全球顶尖出版社Wiley出版发行，是一份经同行评审的、多学科的、在线开放获取的医学期刊，主要发表在肿瘤学方面具有重大影响的临床、基础和转化研究进展，致力于揭示人类癌症的分子致病机理，提出癌症诊断和治疗的新方法和新技术。
期刊主编由法国笛卡尔大学Guido Kroemer教授（欧洲科学院院士、中国工程院外籍院士）和四川大学华西医院生物治疗国家重点实验室彭勇教授担任，组建了来自全球十多个国家的编委团队，努力发展期刊为具有国际影响力的高水平学术期刊。
MedComm – Oncology秉持对稿件的高质量要求，严格同行评审，专业高效管理，发表涉及癌症的发生机制、早期筛查/预防、精确诊断和靶向治疗等方面的研究成果，范围包括但不限于临床医学、遗传学、生物信息学、分子生物学、细胞生物学、生物化学、药理学、药物化学等。
感兴趣的主题包括但不限于：
·Cancer metabolism
·Non-coding RNA
·Cancer stem cell
·Signal transduction
·Tumour microenvironment and immunology
·Early diagnosis and biomarkers
·Drug discovery
·Gene therapy, cell therapy and immunotherapy
·Artificial intelligence
MedComm – Oncology致力于搭建国际生物医学平台，推动肿瘤学和医学发展，为大家带来有洞见性、有价值的、有影响力的高质量论文。本刊2022-2023年免收论文处理费（APC），对于重要成果采取“快速通道”模式，快速发表。文章类型包括综述（Review）、展望（Perspective）、研究论文（Research Article）、致编辑信函（Letter）、研究亮点（Research Highlight）等。诚挚欢迎生物医学领域的科研工作者、医生、研究生积极投稿。
官网地址
https://onlinelibrary.wiley.com/journal/27696448
投稿地址
https://mc.manuscriptcentral.com/medcomm-oncology
投稿指南Author Guidelines
【杂志社官方网站信息】
1. SUBMISSION
Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/medcomm-oncology
Click here for more details on how to use ScholarOne.
Data protection:
By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.
Preprint policy:
Please find the Wiley preprint policy here.
This journal considers article previously published on preprint servers.
MedComm-Oncology will consider for review articles previously available as preprints. Authors are requested to update any pre-publication versions with a link to the final published article. Authors may also post the final published version of the article immediately after publication.
For help with submissions, please contact: editorial@mc-oncology.org
……
更多详情：
https://onlinelibrary.wiley.com/page/journal/27696448/homepage/author-guidelines